MARY KEMP: Open Payments
NPI 1356567689 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,267 in 102 payments from 29 companies in 2025. Trend: 2023 $2,079 · 2024 $2,066 · 2025 $2,267
Food & beverage: $2,267
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $339 |
| Insulet Corporation | 2 | $247 |
| Radius Health, Inc. | 5 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $138 |
| Abbott Laboratories | 6 | $127 |
| CeQur Corporation | 1 | $122 |
| Amgen Inc. | 7 | $117 |
| Lilly USA, LLC | 5 | $90 |
| Xeris Pharmaceuticals, Inc. | 4 | $87 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $75 |
Products named: Omnipod, Ozempic, Tymlos, JARDIANCE, Wegovy, FREESTYLE LIBRE 3, CeQur Simplicity, MOUNJARO.
Industry payments across VA — which companies pay providers there.
